Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,780.50
Bid: 1,778.50
Ask: 1,779.00
Change: 7.00 (0.39%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,786.50
Low: 1,771.50
Prev. Close: 1,773.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ekes out gains on pharma strength

Mon, 28th Oct 2019 09:17

* FTSE 100 up 0.1%, FTSE 250 up 0.5%

* Astra, GSK offer most support to main bourse

* HSBC falls after profit miss

* Cairn Energy biggest midcap faller
(Adds company news items, changes analyst quote, updates share
moves)

By Muvija M and Shashwat Awasthi

Oct 28 (Reuters) - The exporter-laden FTSE 100
recovered from early losses on Monday despite a rebound in
sterling, boosted by gains in leading drug stocks and as
prospects for a U.S.-China trade agreement powered miners and
industrials.

The blue chip index closed 0.1% higher, lagging peers on
Wall Street and in Europe as a near 4% drop in HSBC
after an underwhelming earnings update, and a slide in dollar
earners, capped gains.

The more domestically-focused FTSE 250 outperformed
with a 0.5% rise ahead of a parliamentary vote on Prime Minister
Boris Johnson's demand for a general election.

AstraZeneca climbed as much 3.6% after saying a
combination of its cancer drug, Imfinzi, along with chemotherapy
helped curb progression of lung cancer in a late-stage study.
The shares ended up 1%.

In the same sector GlaxoSmithKline added 2.2% after
the company said it had begun a late-stage study of its
experimental antibiotic in patients with urinary tract
infections and gonorrhoea.

Gains of between 1.3% and 2.2% in Glencore, BHP
and Anglo American powered the mining sector
, exposed to the international trade scenario, to a
one-month high after U.S. President Donald Trump said he
expected to sign a significant part of a trade deal with China
ahead of schedule.

EARNINGS TARGET

By contrast HSBC shares suffered their biggest
one-day loss in eight months as the bank's third-quarter profit
missed expectations and it dropped its 2020 earnings target amid
macro-economic uncertainties.

The update dragged a sub-index of banks 2.4%
lower.

Financial companies have also had to adjust to a lower
interest rate environment this year as central banks globally
move to loosen monetary policies to cushion an impact from trade
tensions.

To that end, markets are also keeping a close eye on the
U.S. Federal Reserve's meeting this week for more support to the
slowing global economy.

"We see the Fed cutting rates this week and possibly again
next year, as it seeks to provide insurance against a broad
economic slowdown", BlackRock analysts wrote in their weekly
note.

In addition, UK firms face a lack of clarity at home as
lawmakers and Prime Minister Boris Johnson feud over Brexit.
Earlier in the day, the European Union agreed a three-month
flexible delay to the Oct. 31 exit date.

Among midcaps, there was an 8.1% plunge in Cairn Energy
after the oil and gas explorer abandoned an offshore
well in Mexico.

Aston Martin, which has plunged nearly 80% from its
2018 debut, dropped 8.5% after Bank of America Merrill Lynch
downgraded the stock.
(Reporting by Muvija M and Shashwat Awasthi
Additional reporting by Safia Infant in Bengaluru
Editing by Arun Koyyur and David Holmes
)

More News
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more
23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

Read more
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.